The wearable cardioverter-defibrillator

Circulation

Volumn 134, Issue 9, 2016, Pages 644-646

  Lee, Byron K ^a   Olgin, Jeffrey E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Editorials

Indexed keywords

CARDIOMYOPATHY; DEFIBRILLATION; DEFIBRILLATOR; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL DEVICE COMPLICATION; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUDDEN CARDIAC DEATH; TREATMENT INDICATION; WEARABLE CARDIOVERTER DEFIBRILLATOR; HEALTH CARE QUALITY;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; STANDARD OF CARE;

EID: 84984697567     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.024287     Document Type: Review

References (15)

1. Piccini JP Sr, Allen LA, Kudenchuk PJ, Page RL, Patel MR, Turakhia MP, Americann Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the Americann Heart Association. Circulation 2016 133 1715 1727. doi: 10.1161/CIR.0000000000000394
2. Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, Boehmer J, Harvey M, Heilman MS, Szymkiewicz SJ, Moss AJ, WEARIT Investigators and Coordinators; BIROAD Investigators and Coordinators Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 2004 27 4 9
3. Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ, Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol 2013 62 2000 2007. doi: 10.1016/j.jacc.2013.05.086
4. Kao AC, Krause SW, Handa R, Karia D, Reyes G, Bianco NR, Szymkiewicz SJ, Wearable defibrillator use In heart Failure (WIF) Investigators Wearable defibrillator use in heart failure (WIF): results of a prospective registry. BMC Cardiovasc Disord 2012 12 123. doi: 10.1186/1471-2261-12-123
5. Mitrani RD, McArdle A, Slane M, Cogan J, Myerburg RJ, Wearable defibrillators in uninsured patients with newly diagnosed cardiomyopathy or recent revascularization in a community medical center. Am Heart J 2013 165 386 392. doi: 10.1016/j.ahj.2012.12.014
6. Rao M, Goldenberg I, Moss AJ, Klein H, Huang DT, Bianco NR, Szymkiewicz SJ, Zareba W, Brenyo A, Buber J, Barsheshet A, Wearable defibrillator in congenital structural heart disease and inherited arrhythmias. Am J Cardiol 2011 108 1632 1638. doi: 10.1016/j.amjcard.2011.07.021
7. Saltzberg MT, Szymkiewicz S, Bianco NR, Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 2012 18 21 27. doi: 10.1016/j.cardfail.2011.09.004
8. Zishiri ET, Williams S, Cronin EM, Blackstone EH, Ellis SG, Roselli EE, Smedira NG, Gillinov AM, Glad JA, Tchou PJ, Szymkiewicz SJ, Chung MK, Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol 2013 6 117 128. doi: 10.1161/CIRCEP.112.973552
9. Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD, Tchou PJ, Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol 2010 56 194 203. doi: 10.1016/j.jacc.2010.04.016
10. Wäßnig NK, Günther M, Quick S, Pfluecke C, Rottstädt F, Szymkiewicz SJ, Ringquist S, Strasser RH, Speiser U, Experience with the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circulation 2016 134 635 643. 10.1161/CIRCULATIONAHA.115.019124
11. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991 324 781 788. doi: 10.1056/NEJM199103213241201
12. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998 280 605 613
13. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ, DINAMIT Investigators Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004 351 2481 2488. doi: 10.1056/NEJMoa041489
14. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, Kornacewicz-Jach Z, Sredniawa B, Lupkovics G, Hofgärtner F, Lubinski A, Rosenqvist M, Habets A, Wegscheider K, Senges J, IRIS Investigators Defibrillator implantation early after myocardial infarction. N Engl J Med 2009 361 1427 1436. doi: 10.1056/NEJMoa0901889
15. Brooks GC, Lee BK, Rao R, Lin F, Morin DP, Zweibel SL, Buxton AE, Pletcher MJ, Vittinghoff E, Olgin JE, PREDICTS Investigators Predicting persistent left ventricular dysfunction following myocardial infarction: the PREDICTS Study. J Am Coll Cardiol 2016 67 1186 1196. doi: 10.1016/j.jacc.2015.12.042